Immunservice GmbH
Hamburg
About Immunservice GmbH
Immunservice is focused on research about immune hormone interleukin-2 and offers resources and insights to implement diagnostic and pharmaceutical developments of it. It develops solutions that focus on human and animal immunotherapy, and human cell therapy. Immunservice develops medicinal forms of interlelukin-2 that enable patients with lung metastases to prevent suffocation. Immunservice was founded by Edith Huland in 2007.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2015)
- Website: immunservice.com
- Phone: 494038017857279
Industries & Categories
Biotechnology, Developer Tools, Medical, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/immunservice-gmbh-2732743 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.